Atlas Trials

PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19

Clinical trial NCT04497324 · COMPLETED

Trial details

NCT number
NCT04497324
Sponsor
Universidad Peruana Cayetano Heredia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-09-21
Primary completion
2021-04-17
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.